| Literature DB >> 24969140 |
Abstract
Escherichia coli (E. coli) consists of commensal (ComEC) and diarrhoeagenic (DEC) groups. ComEC are detected using traditional culture methods. Conformational steps are performed after culturing if it is required to test for the presence of DEC, increasing cost and time in obtaining the results. The aim of this study was to develop a single-step multiplex polymerase chain reaction (m-PCR) that can simultaneously amplify genes associated with DEC and ComEC, with the inclusion of controls to monitor inhibition. A total of 701 samples, taken from clinical and environmental water sources in South Africa, were analysed with the optimised m-PCR which targeted the eaeA, stx1, stx2, lt, st, ial, eagg, astA and bfp virulence genes. The mdh and gapdh genes were included as an internal and external control, respectively. The presence of the external control gapdh gene in all samples excluded any possible PCR inhibition. The internal control mdh gene was detected in 100 % of the environmental and 85 % of the clinical isolates, confirming the classification of isolates as E. coli PCR positive samples. All DEC types were detected in varying degrees from the mdh positive environmental and clinical isolates. Important gene code combinations were detected for clinical isolates of 0.4 % lt and eagg. However, 2.3 % of eaeA and ial, and 8.7 % of eaeA and eagg were reported for environmental water samples. The E. coli astA toxin was detected as positive at 35 and 17 % in environmental isolates and clinical isolates, respectively. Interestingly, 25 % of the E. coli astA toxin detected in environmental isolates and 17 % in clinical isolates did not contain any of the other virulence genes tested. In conclusion, the optimised single-step 11-gene m-PCR reactions could be successfully used for the identification of pathogenic and non-pathogenic E. coli types. The m-PCR was also successful in showing monitoring for PCR inhibition to ensure correct reporting of the results.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24969140 PMCID: PMC4150989 DOI: 10.1007/s11274-014-1690-4
Source DB: PubMed Journal: World J Microbiol Biotechnol ISSN: 0959-3993 Impact factor: 3.312
Bacterial strains used in molecular characterisation
| Bacterial strain | Reference nr | Genes present |
|---|---|---|
|
| ATCC 25922 |
|
| Enterohaemorrhagic (EHEC) | ESCCO 21b |
|
| Enteroinvasive (EIEC) | ESCCOS ATCC 43893b |
|
| Enterotoxigenic (ETEC) | ESCCO 22b |
|
| Enteropathogenic (EPEC) | S-ESCCO 16 Plb |
|
| Enteroaggregative (EAEC) | ESCCO 14b |
|
aEnvironmental isolate confirmed by API 20E (OMNIMED®) and PCR as commensal E. coli
bStrains purchased from National Health Laboratory Services (NHLS)
Primers used in the m-PCR reaction
| Pathogen | Primer | Sequence(5′-3′) | Size (bp) | Conc. (µM) | Reference |
|---|---|---|---|---|---|
|
|
| GGT ATG GAT CGT TCC GAC CT | 304 | 0.1 | Tarr et al. ( |
|
| GGC AGA ATG GTA ACA CCA GAG T | ||||
| EIEC |
| GGT ATG ATG ATG ATG AGT CCA | 650 | 0.2 | López-Saucedo et al. ( |
|
| GGA GGC CAA CAA TTA TTT CC | ||||
| EHEC/Atypical EPEC |
| CTG AAC GGC GAT TAC GCG AA | 917 | 0.3 | Aranda et al. ( |
|
| CCA GAC GAT ACG ATC CAG | ||||
| Typical EPEC |
| AAT GGT GCT TGC GCT TGC TGC | 410 | 0.3 | Aranda et al. ( |
|
| TAT TAA CAC CGT AGC CTT TCG CTG AAG TAC CT | From this study | |||
| EAEC |
| AGA CTC TGG CGA AAG ACT GTA TC | 194 | 0.2 | Pass et al. ( |
|
| ATG GCT GTC TGT AAT AGA TGA GAA C | ||||
| EHEC |
| ACA CTG GAT GAT CTC AGT GG | 614 | 0.5 | Moses et al. ( |
|
| CTG AAT CCC CCT CCA TTA TG | ||||
|
| CCA TGA CAA CGG ACA GCA GTT | 779 | 0.3 | Moses et al. ( | |
|
| CCT GTC AAC TGA GCA CTT TG | ||||
| ETEC |
| GGC GAC AGA TTA TAC CGT GC | 360 | 0.1 | Pass et al. ( |
|
| CGG TCT CTA TAT TCC CTG TT | ||||
|
| TTT CCC CTC TTT TAG TCA GTC AAC TG | 160 | 0.5 | Pass et al. ( | |
|
| GGC AGG ATT ACA ACA AAG TTC ACA | ||||
|
|
| GCC ATC AAC ACA GTA TAT CC | 106 | 0.3 | Kimata et al. ( |
|
| GAG TGA CGG CTT TGT AGT C | ||||
| External control |
| GAG TCA ACG GAT TTG GTC GT | 238 | 0.3 | Mbene et al. ( |
|
| TTG ATT TTG GAG GGA TCT CG |
NB: F forward primer, R reverse primer
Specificity of the m-PCR
| Bacterial strain | Source | Genes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| ||
| Commensal | NHLS | + | − | − | − | − | − | + | − | − | − | |
| Enterohaemorrhagic | NHLS | + | + | − | + | + | − | − | + | − | − | − |
| Enteropathogenic | NHLS | + | + | + | − | − | − | − | + | − | − | + |
| Enteroaggregative | NHLS | + | − | − | − | − | − | − | + | − | + | − |
| Enterotoxigenic | NHLS | + | − | − | − | − | − | + | + | + | − | − |
| Enteroinvasive | NHLS | + | − | − | − | − | + | − | + | − | − | − |
|
| NHLS | + | − | − | − | − | + | − | + | − | − | − |
|
| NHLS | + | − | − | − | − | + | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | + | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | + | + | − | − | − | + | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NTCC | − | − | − | − | − | − | − | + | − | − | − |
|
| NTCC | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NCTC | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NCTC | − | − | − | − | − | − | − | + | − | − | − |
|
| ATCC | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| ATCC | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
|
| NHLS | − | − | − | − | − | − | − | + | − | − | − |
Fig. 1Agarose gel of the PCR products obtained for the E. coli multiplex PCR (lane 2). No template control (NTC) in (lane 2). The molecular weight marker is shown in (lane 1)
Fig. 2Agarose gel of the PCR products obtained from samples (lane 4–11, 13–18). No template control (NTC) in (lane 2). The molecular weight marker is shown in (lane 1 and 12). The positive reference control is shown in (lane 3)
PCR results obtained from the single isolates of the clinical and environmental isolates and water samples from the Colilert® Quanti-Tray®/2000
Distribution of the astA toxin gene combined with the virulence genes for isolates, environmental isolates and water samples
Gene combinations from clinical and environmental isolates
| Patho-type | Gene combinations | Clinical isolates (n) | Environmental isolates (n) | References |
|---|---|---|---|---|
| Atypical EPEC |
| 32 | 46 | Aranda et al. ( Botkin et al. ( |
| EHEC |
| 0 | 4 | Müller et al. ( |
|
| 1 | 0 | ||
|
| 0 | 1 | ||
|
| 0 | 1 | ||
|
| 0 | 1 | ||
| Typical EPEC |
| 2 | 51 | Kaper et al. ( |
|
| 2 | 6 | Botkin et al. ( | |
| ETEC |
| 0 | 3 | Presterl et al. ( |
|
| 8 | 6 | ||
|
| 6 | 3 | ||
|
| 1 | 0 | ||
|
| 0 | 4 | ||
|
| 0 | 15 |